INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2012
Total net assets |
£128.7m |
NAV per share |
232.0p |
Share price |
203.3p |
Total value of unquoted investments |
£21.1m |
Total number of portfolio companies |
69 |
Cash |
6% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
13.95% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Gilead Sciences Aptiv Solutions |
6.8 4.7 4.5 |
Celgene Alexion |
4.2 4.0 |
Insulet Pharmaxis Biogen |
3.4 3.1 2.9 |
Teva Ariad |
2.7 2.4 |
|
----------- |
Total |
38.7 |
Geographical Allocation |
% |
United States & Canada |
80 |
Europe |
8 |
Israel Australia |
3 3 |
Cash |
6 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
78 |
Unquoted |
16 |
Cash |
6 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 AUGUST 2012